Shopping Cart
- Remove All
- Your shopping cart is currently empty
sEH/HDAC6-IN-2 is an effective dual inhibitor of soluble epoxide hydrolase (sEH) and HDAC6, demonstrating IC50 values of 0.9 nM for human sEH, 46.8 nM for mouse sEH, and 8 nM for HDAC6. It is used in research focused on inflammatory pain.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | sEH/HDAC6-IN-2 is an effective dual inhibitor of soluble epoxide hydrolase (sEH) and HDAC6, demonstrating IC50 values of 0.9 nM for human sEH, 46.8 nM for mouse sEH, and 8 nM for HDAC6. It is used in research focused on inflammatory pain. |
Targets&IC50 | HDAC2:0.492 μM, HDAC1:1.151 μM, Human sEh:0.0009 μM, Mouse sEh:0.0468 μM, HDAC8:0.062 μM, HDAC6:0.008 μM, HDAC11:0.464 μM, HDAC3:1.276 μM |
In vitro | sEH/HDAC6-IN-2 exhibits selective inhibition towards HDAC6, demonstrated by its significant selectivity indices (HDAC1/HDAC6 = 144, HDAC2/HDAC6 = 62, HDAC3/HDAC6 = 160, HDAC8/HDAC6 = 8, HDAC11/HDAC6 = 58). When administered at concentrations of 1-2 μM for 24 hours, sEH/HDAC6-IN-2 (compound 28g) induces an increase in acetylation of α-tubulin without affecting histone H3, indicating a selective inhibition of HDAC6. |
In vivo | sEH/HDAC6-IN-2 (compound 28g; 30 mg/kg; intraperitoneal injection; single dose) alleviated inflammation-induced pain in mice following formalin exposure. |
Molecular Weight | 580.02 |
Formula | C27H32ClF2N5O5 |
Cas No. | 3009011-58-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.